The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 84.00
Bid: 83.80
Ask: 84.40
Change: 0.40 (0.48%)
Spread: 0.60 (0.716%)
Open: 85.00
High: 85.20
Low: 82.20
Prev. Close: 83.60
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Long Term Incentive Plan Awards

7 Oct 2020 12:10

RNS Number : 3995B
Costain Group PLC
07 October 2020
 

 

Costain Group PLC

(the "Company")

 

LONG TERM INCENTIVE PLAN AWARDS

Costain announces the following grant of a share award to the chief executive officer of the Company.

 

On 7 October 2020, awards were made under the Costain Group PLC 2014 Long Term Incentive Plan (the "LTIP") over ordinary shares of 50p each in the Company in the form of options with a nil exercise price (the "Awards"). An award was granted to Alex Vaughan over 553,909 shares. No consideration was paid for the grant of the Awards.

 

The vesting of the Awards is subject to the satisfaction of performance conditions assessed over the three financial years ending 31 December 2022. As set out in the Company's 2019 Directors' Remuneration Report, the performance conditions are based on EPS as regards two thirds of each award and cash conversion as regards one third of each award. The proposed performance targets for the EPS condition were set out in the 2019 Directors' Remuneration Report. However, having regard to the change in circumstances, including the capital raising in May 2020, the Remuneration Committee has revised the EPS targets. The Committee considers that the revised targets are achievable but still require the delivery of EPS performance which is appropriately stretching. The revised EPS targets are set out below. The cash conversion targets have not changed from those proposed in the Directors' Remuneration Report, but are also stated below for completeness. In addition to revising the EPS targets, the Committee has taken into account market conditions and reduced the quantum of Alex Vaughan's award from 100% of salary to 55% of salary.

 

Vesting

EPS(aggregate EPS over the three year performance period)

Cash conversion(average cash conversion over the performance period)

Below threshold: 0%

Below 22.6 pence

Below 80%

Threshold: 15%

22.6 pence

80%

Between threshold and maximum: 15% - 100% pro rata on a straight-line basis

Between 22.6 pence and 26.7 pence

Between 80% and 100%

Maximum: 100%

26.7 pence

100%

 

The extent to which the Award granted to Alex Vaughan vests will normally be determined following the end of the three financial year performance period ending 31 December 2022, but the Award will not normally be released (so that it can be exercised) until the end of a further two year period (with no further performance conditions required after vesting).

 

The Remuneration Committee may reduce the extent to which the Award vests if the Committee considers that any of the value at vesting represents a "windfall gain", taking into account such factors as the Committee determines.

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

a)

Name

ALEXANDER JOHN VAUGHAN

2.

Reason for the notification

a)

Position /status

CHIEF EXECUTIVE OFFICER/ PDMR

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

COSTAIN GROUP PLC

b)

LEI code

213800PKIJBZ2EDTKC88

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES OF 50 PENCE EACH

 

ISIN: GB00B64NSP76

b)

Nature of the transaction

GRANT OF 553,909 OPTIONS UNDER THE COMPANY'S 2014 LONG TERM INCENTIVE PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

553,909

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

 

7 OCTOBER 2020

f)

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

 

7 OCTOBER 2020

 

Enquiries:

Costain Group PLC

Tel: 01628 842 444

Sharon Harris, Company Secretary

MHP CommunicationsTim Rowntree, Peter Hewer

Tel: 020 3128 8100

costain@mhpc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPGAUUUPUGGM
Date   Source Headline
16th Oct 20187:00 amRNS2018 Interim Dividend - Scrip Alternative
26th Sep 20183:57 pmRNSHolding(s) in Company
24th Sep 20181:00 pmRNSDirector/PDMR Shareholding
20th Sep 20188:41 amRNSScrip Dividend Reference Price
23rd Aug 20187:00 amRNSNetwork Rail 'Meerkat' Technology Contract
22nd Aug 20187:00 amRNSHalf-year Report
21st Aug 20187:00 amRNSConnected Vehicle Technology Contract
10th Jul 20189:03 amRNSHolding(s) in Company
3rd Jul 20187:00 amRNSTrading Update
2nd Jul 20188:00 amRNSBlock listing Interim Review
29th Jun 20183:37 pmRNSHolding(s) in Company
22nd Jun 20188:38 amRNSHolding(s) in Company
14th Jun 20187:00 amRNSCostain expands to new technology centre
5th Jun 20183:49 pmRNSDirector/PDMR Shareholding
4th Jun 20187:00 amRNSCostain awarded M6 smart motorway contract
31st May 20189:00 amRNSTotal Voting Rights
15th May 20187:00 amRNSDividend - Scrip Alternative
8th May 20184:29 pmRNSResult of AGM
8th May 20187:00 amRNSCostain awarded technology contract
8th May 20187:00 amRNSAGM Statement
30th Apr 20188:00 amRNSTotal Voting Rights
19th Apr 20188:55 amRNSScrip Dividend Reference Price
11th Apr 20181:16 pmRNSDirector/PDMR Shareholding
4th Apr 20182:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20189:41 amRNSDirector Declaration
29th Mar 20189:01 amRNSTotal Voting Rights
26th Mar 20188:50 amRNSHolding(s) in Company
16th Mar 20189:18 amRNSNotice of AGM
13th Mar 201812:53 pmRNSExercise of Nil Cost Options
13th Mar 201811:58 amRNSHolding(s) in Company
12th Mar 20181:49 pmRNSHolding(s) in Company
6th Mar 20189:00 amRNSLong Term Incentive Plan - Listing Application
1st Mar 20187:00 amRNSFinal Results
28th Feb 20189:00 amRNSTotal Voting Rights
28th Feb 20188:38 amRNSHolding(s) in Company
26th Feb 201810:07 amRNSDirectorate Change
31st Jan 20189:00 amRNSTotal Voting Rights
11th Jan 201812:32 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSYear End Trading Update
2nd Jan 20188:00 amRNSBlock listing Interim Review
2nd Jan 20188:00 amRNSTotal Voting Rights
18th Dec 201711:50 amRNSHolding(s) in Company
14th Dec 20177:00 amRNSManagement Consultancy Framework Appointment
8th Dec 20178:00 amRNSDirector/PDMR Shareholding
30th Nov 20178:00 amRNSTotal Voting Rights
28th Nov 20173:18 pmRNSHolding(s) in Company
24th Nov 201711:28 amRNSBoard Notification - External Directorship
23rd Nov 20172:48 pmRNSHolding(s) in Company
17th Nov 201710:13 amRNSAppointment of Non Executive Director
1st Nov 201711:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.